Health
Breakthrough Cancer Vaccine Shows 90% Efficacy in Phase 2 Trials at Tata Memorial
Tata Memorial's personalized mRNA cancer vaccine shows 90% reduction in recurrence in Phase 2, with plans to cut co...
Search through all articles, categories, tags, and authors
Found 2 results for "Tata Memorial"
Tata Memorial's personalized mRNA cancer vaccine shows 90% reduction in recurrence in Phase 2, with plans to cut co...
Tata Memorial's personalized mRNA cancer vaccine shows 90% reduction in recurrence in Phase 2, with plans to cut co...